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Abstract
Introduction: We present a case of an unusual clinical manifestation of Guillain-Barre syndrome following a pre-
existing herpes virus infection. Although there have been several reports describing the co-existence of herpes
virus infection and Guillain-Barre syndrome, we undertook a more in-depth study of the cross-reactivity between
herpes viruses and recommend a follow-up study based on serology tests.
Case presentation: A 39-year-old healthy Caucasian man with Guillain-Barre syndrome presented to our facility
initially with sensory disturbance, followed by an atypical descending pattern of clinical progression. On physical
examination, our patient showed hot and cold temperature sensory disturbance under the T4 vertebrae level,
symmetrically diminished muscle power mainly to his lower limbs, blurred vision, a loss of taste and paresis and
diminished reflexes of his lower limbs. Serology test results for common viruses on hospital admission were
positive for cytomegalovirus immunoglobulin M, cytomegalovirus immunoglobulin G, herpes simplex virus
immunoglobulin M, herpes simplex virus immunoglobulin G, Epstein-Barr virus immunoglobulin M, and varicella
zoster virus immunoglobulin G, borderline for Epstein-Barr virus immunoglobulin G and negative for varicella zoster
virus immunoglobulin M. At one month after hospital admission his test results were positive for cytomegalovirus
immunoglobulin M, cytomegalovirus immunoglobulin G, herpes simplex virus immunoglobulin G, Epstein-Barr virus
immunoglobulin G, varicella zoster virus immunoglobulin G, borderline for herpes simplex virus immunoglobulin M
and negative for Epstein-Barr virus immunoglobulin M and varicella zoster virus immunoglobulin M. At his six
month follow-up, tests were positive for cytomegalovirus immunoglobulin G, herpes simplex virus immunoglobulin
M, herpes simplex virus immunoglobulin G, Epstein-Barr virus immunoglobulin G and varicella zoster virus
immunoglobulin G and negative for cytomegalovirus immunoglobulin M, Epstein-Barr virus immunoglobulin M
and varicella zoster virus immunoglobulin M.
Conclusions: The clinical manifestation of Guillain-Barre syndrome in our patient followed a combined herpes virus
infection. The cross-reactivity between these human herpes viruses may have a pathogenic as well as evolutionary
significance. Our patient showed seroconversion at an early stage of Epstein-Barr virus immunoglobulin M to
immunoglobulin G antibodies, suggesting that Epstein-Barr virus might have been the cause of this syndrome.
Even if this case is not the first of its kind to be reported, it may contribute to a better understanding of the
disease and the cross-reaction mechanisms of herpes virus infections. This case report may have a broader clinical
impact across more than one area of medicine, suggesting that cooperation between different specialties is always
in the patient’s best interest.
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Introduction
Guillain-Barre syndrome (GBS) is an acute polyradiculo-
neuropathy marked by flaccid areflexic paralysis.
Although GBS has been viewed as a unitary disorder, it
is widely accepted that it includes distinctive subtypes,
such as acute inflammatory demyelinating polyradiculo-
neuropathy, acute motor axonal neuropathy, acute
motor-sensory axonal neuropathy and Miller-Fisher syn-
drome, amongst others [1,2]. Both sexes are equally
affected; healthy adults are more commonly affected
than children. The onset of the symptoms of sudden
and severe paralysis may occur, but the overall prog-
nosis is good, with approximately 85% of survivors mak-
ing a good functional recovery. Early diagnosis and
progress in methods of support have decreased mortality
rates and improved outcome.
GBS is considered a post-infectious, immune-mediated
disease. Symptoms of a preceding upper respiratory tract
infection or gastrointestinal infection are often reported
prior to the onset of GBS symptomatology. Campylo-
bacter jejuni, cytomegalovirus (CMV), Epstein-Barr virus
(EBV) and Mycoplasma pneumoniae have been identi-
fied as the predominant causes associated with GBS.
The type of antecedent infection in GBS is related to
specific serum anti-ganglioside antibodies and clinical
subgroups. Many of the identified infectious agents may
induce antibody production against specific gangliosides
and glycolipids, such as GM1 and GD1b, distributed
throughout the myelin in the peripheral nervous system.
Molecular mimicry between infectious agents and gang-
liosides plays an important role in inducing these anti-
bodies [3,4].
Case presentation
A 39-year-old Caucasian man was referred to our emer-
gency department due to a sudden loss of hot and cold
sensation when taking a shower, followed by a progres-
sive instability and weakness of his lower extremities.
Our patient also complained of diplopia, dim vision and
circumoral numbness. Our patient reported an upper
respiratory tract infection for which he was being trea-
ted with an antibiotic (macrolide). Neurologic sympto-
matology began a few days later. His medical history
was unremarkable apart from seasonal asthma. He used
to smoke 20 cigarettes per day and drink alcohol only
on social occasions. He was the father of two children.
No high-risk sexual behavior was reported.
On physical examination, he had hot and cold tem-
perature sensory disturbance under the T4 vertebrae
level, symmetrically diminished muscle power mainly to
his lower limbs, blurred vision and a loss of taste.
Further neurological examination revealed paresis and
diminished reflexes of his lower limbs; mainly the jerk
ankle and patellar reflex. Cerebral pathology results fol-
lowing an MRI scan were negative. However, our patient
reported a loss of balance, a failure to stand or walk and
numbness. In summary, our patient showed progressive
weakness of his lower limbs due to neuropathy, are-
flexia, sensory involvement and cerebella ataxia, and
with the duration of the disease being less than four
weeks, the required and some of the supportive diagnos-
tic criteria for GBS were met. Other physical examina-
tions were normal.
Two lumbar punctures were performed, the first on
admittance and the second 14 days following com-
mencement of the symptoms (Table 1). The diagnostic
tests are summarized chronologically in Table 2. Serol-
ogy tests for neurotropic viruses were requested for dif-
ferential diagnosis purposes. Hepatitis, human
immunodeficiency virus (HIV) and varicella zoster virus
(VZV) test results were negative, as were results for
West Nile virus (WNV) with indirect enzyme-linked
immunosorbent assay (ELISA) immunoglobulin G (IgG)
and M antibody capture (MAC)-ELISA (IgM). However,
CMV, herpes simplex virus (HSV) and EBV IgM anti-
body test results were positive. Blood CMV antigen and
polymerase chain reaction (PCR) tests for CMV were
negative, as was the PCR test for CMV from the cere-
brospinal fluid (CSF). Blood, urine and CSF cultures
were sterile. A tuberculin skin test and CSF culture for
tuberculosis (TBC) were negative. Serology tests were
repeated one month after hospital admittance and at a
six month follow-up appointment. The comparative
results are summarized in Table 2.
Results of a chest X-ray were negative. A brain MRI
scan showed no abnormalities of the cerebral parench-
yma, but a slight inflammation of the ethmoid and right
mastoid sinus was noted. In view of the neurological
findings, his jugular and lumbar spinal column were
scanned. No abnormalities except degenerative lesions
and slightly slipped disks were noted, but these findings
were irrelevant to the clinical symptoms. Brain, lung
and abdominal computed tomography showed no
abnormalities.
Table 1 Comparison of the two lumbar puncture (LP)
results from cerebrospinal fluid (CSF)
Result First LP Second LP
Cells per mm3 5 20
Glucose (mg/dL) 75 64
Protein (g/dL) 0.30 1
Lactate dehydrogenase (U/L) 51 56
Gram staining Negative Negative
Cryptococcus Negative Negative
PCR CMV Negative -
CMV = cytomegalovirus; PCR = polymerase chain reaction.
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Electromyography gave a mildly diminished activity of
the examined muscles; the palpebra sphincter (right and
left), first inter-osseus dorsalis muscle (right) and ante-
rior tibialis (right). After infra-orbital nerve stimulation,
no R1 responses were received bilaterally. Retarded R2
responses were received, while the R2 response of the
left side was significantly lower. Electroneurography
indicated absence of an f wave when his right median,
ulnar and peroneal nerves were stimulated. Absence of
an f wave was also observed when his left tibial nerve
was stimulated, indicating a mixed demyelinative poly-
neuropathy with a conduction blockade in multiple
nerves and mild axial damage.
Our patient received 40 g intravenous Immunoglobu-
lin for a duration of five days based on clinical suspi-
cion. Notably, the CSF albumin became elevated (1 g/
dL) only after the second lumbar puncture was per-
formed two weeks after the onset of symptoms. Our
patient received an additional 40 g of intravenous
Immunoglobulin a few days later, for a duration of three
days, in an attempt to ameliorate the final clinical out-
come. Relapse can occur in patients who are treated
early in the course of GBS and improve, and brief
retreatment with the original therapy is usually effective
in these cases [5,6]. On presentation with positive CMV
IgM antibody test results, we applied an anti-CMV
regime with ganciclovir intravenously 500 mg twice
daily. The decision was taken to try to ameliorate our
patient’s neurological condition, which required him to
remain resting in bed as any change in position caused
inconvenience and a sense of falling. Intense physiother-
apy was applied soon after diagnosis. Our patient mark-
edly improved within two weeks. At that time, while
still under anti-CMV treatment, he was able to sit up in
bed and on a chair. Later on he was able to stand with
support and also progressively take a few steps. After
improvement of his clinical condition, our patient was
discharged with appropriate follow-up.
Discussion
Our patient presented to our emergency department
using a wheelchair due to an inability to walk or stand
up from a sitting position. The onset of symptoms was
abrupt following an upper respiratory tract infection.
Our differential diagnosis pointed to a type of GBS,
which initially appeared with a sensory disturbance (hot
and cold sensation) but was followed by a quite atypical
descending progression, or other post-infectious neuro-
logic diseases, including HIV, CMV, HSV, EBV, WNV,
C. jejuni, Haemophilus influenzae, Lyme disease and
TBC [7]. As suggested by Kaida et al. [8] in a recent
review, the mechanism of action of infectious microor-
ganisms that induce GBS may be attributed to the mole-
cular mimicry of lipo-oligosaccharide genes that are
responsible for the formation of human ganglioside-like
lipo-oligosaccharide structures. Other causes, such as
multiple sclerosis (MS) or other demyelinating syn-
dromes, diabetes mellitus, B12 vitamin deficiency, drugs
and chemical neuropathies were excluded following his-
torical, clinical, laboratory and imaging tests. Examina-
tion for vasculitides, Sjögren’s syndrome, sarcoidosis and
paraneoplastic neuropathy proved negative.
Infection with CMV is the most common antecedent
virus infection in GBS, as identified by the presence of
IgM antibodies in 10% to 15% of patients at the onset of
this disease. However, antiviral therapy is not classically
recommended in GBS, as the disease is considered post-
infectious. Recently, the presence of CMV DNA has
been found in almost one-third of serum and CSF sam-
ples from patients with GBS who are positive for CMV-
specific antibodies at the onset of the neurological dis-
ease. Furthermore, the time of lumbar puncture was cri-
tical for the detection of CMV DNA, as the probability
of the presence of CMV DNA decreased significantly
following an increase of the interval between onset of
GBS and puncture. This association suggests that even
more patients may carry CMV in CSF at a very early
stage of GBS [9]. These findings indicate a link between
neurological disease and CMV infection, but the clinical
relevance remains to be elucidated.
The presence of herpes virus DNA in post-mortem
tissue of patients suffering from epilepsy provides strong
correlative evidence that this pathogen plays an
Table 2 Diagnostic tests and their results in
chronological order (blood)
Diagnostic test First day First month Six months
CMV IgM + + -
CMV IgG + + +
HSV IgM + Borderline +
HSV IgG + + +
EBV IgM + - -
EBV IgG Borderline + +
VZV IgM - - -
VZV IgG + + +
WNV IgM - NA NA
WNV IgG - NA NA
VDRL - NA NA
HIV - NA NA
HBV - NA NA
HCV - NA NA
CMV Ag - NA NA
PCR CMV - NA NA
CMV Ag = cytomegalovirus antigenemia; HBV = hepatitis B virus; HCV =
hepatitis C virus; HSV = herpes simplex virus; NA = not applicable; PCR =
polymerase chain reaction; VDRL = Venereal Disease Research Laboratory; VZV
= Varicella zoster virus; WNV = West Nile virus.
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important role in seizure circuits in the brain. In ani-
mal models, HSV-1 infection via the corneal route
results in infection of the trigeminal ganglia and the
transport of the virus into the central nervous system.
At the neuronal level, HSV-1 infection causes a long-
lasting reduction in the depolarizing membrane poten-
tial, thus resulting in a hyperexcitable neuronal state
[10]. Like HSV-1, WNV has a significant propensity
for infecting the limbic region, especially the hippo-
campus. Depending on the strain of WNV, infection in
mice may or may not cause necrotic lesions with focal
hemorrhages [11].
Conclusions
In our patient, the clinical manifestation of GBS fol-
lowed a combined herpes virus infection (CMV, EBV,
HSV). Cross-reactivity between human herpes viruses
has been suggested in a recent study in which the EBV
virion glycoprotein gp85 was immunopreciptated by
antisera to HSV-1, HSV-2 and CMV. Moreover, antisera
to CMV and EBV neutralized the infectivity of both
HSV-1 and HSV-2 at high concentrations, suggesting
that cross-reactivity between these human herpes viruses
may have pathogenic as well as evolutionary significance
[12]. Performing an immunoprecipitation technique or
immunoabsorption study using glycolipids or glycopro-
teins purified from EBV or CMV from patient serum
samples would provide evidence for supporting the
cross-reactivity between human herpes viruses in the
case of our patient, but unfortunately these methods are
not available in our hospital. Moreover, examination for
anti-ganglioside antibodies was suggested to our patient
in order to accommodate the diagnosis of GBS, but he
did not give permission because the test was not avail-
able locally and consequently our patient would have
had to pay for it privately.
This is an unusual clinical manifestation of GBS that
initially appeared with a sensory disturbance (loss of
cold and hot sensation) and followed a rather atypical
descending clinical progress. As shown in Table 2, CMV
IgM and IgG test results were positive on admittance
and afterwards remained positive. However, EBV IgM
test results were positive on admittance but became
negative. The EBV IgG result was borderline on admit-
tance and later remained positive. Our patient showed
seroconversion at an early stage of EBV IgM to IgG
antibodies, suggesting that EBV had been the cause of
this syndrome. From our clinical and laboratory find-
ings, we conclude that the method of seroconversion of
EBV and CMV is very important. Even if this case is not
the first report of this kind in the literature, we believe
that it may contribute to the better understanding of
the disease and the cross-reaction mechanisms of herpes
virus infections.
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